Back
JPMorgan Healthcare Leaders ETF Vs. Celldex Therapeutics, Inc. Industry Stock Comparison
Buy
54
JDOC
JPMorgan Healthcare Leaders ETF
Last Price:
$54.12
Seasonality Move:
-1.56%
Sell
48
CLDX
Celldex Therapeutics, Inc.
Last Price:
$31.05
Seasonality Move:
20.93%
Buy
54
JPMorgan Healthcare Leaders ETF (JDOC)
is a Buy
Is JPMorgan Healthcare Leaders ETF a Buy, Sell or Hold?
-
The current JPMorgan Healthcare Leaders ETF [JDOC] share price is $55.54. The Score for JDOC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
JDOC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Celldex Therapeutics, Inc. (CLDX)
is a Sell
Is Celldex Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Celldex Therapeutics, Inc. [CLDX] share price is $31.05. The Score for CLDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JDOC Stock Price Chart
What is JPMorgan Healthcare Leaders ETF's stock price today?
-
The JPMorgan Healthcare Leaders ETF share price today is $55.54The current trend is moderately bullish and JDOC is experiencing slight selling pressure.
CLDX Stock Price Chart
What is Celldex Therapeutics, Inc.'s stock price today?
-
The Celldex Therapeutics, Inc. share price today is $31.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
JDOC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.52 | Buy |
| Relative Strength Index (14 RSI): | 46.59 | Sell |
| Chaikin Money Flow: | -159 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.57 - 57.47) | Sell |
| Bollinger Bands (100): | (56.26 - 59.18) | Sell |
CLDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 55.97 | Buy |
| Chaikin Money Flow: | 3988094 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.43 - 31.31) | Buy |
| Bollinger Bands (100): | (24.48 - 29.54) | Buy |
JDOC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.99 | Buy |
| 20-day SMA: | 55.46 | Buy |
| 50-day SMA: | 57.44 | Sell |
| 200-day SMA: | 54.72 | Buy |
| 8-day EMA: | 52.47 | Buy |
| 20-day EMA: | 38.44 | Buy |
| 50-day EMA: | 20.93 | Buy |
| 200-day EMA: | 6.2 | Buy |
CLDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.05 | Buy |
| 20-day SMA: | 30.57 | Buy |
| 50-day SMA: | 27.66 | Buy |
| 200-day SMA: | 25.4 | Buy |
| 8-day EMA: | 30.94 | Buy |
| 20-day EMA: | 30.26 | Buy |
| 50-day EMA: | 28.67 | Buy |
| 200-day EMA: | 26.26 | Buy |
JPMorgan Healthcare Leaders ETF Earnings Growth & JDOC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Celldex Therapeutics, Inc. Earnings Growth & CLDX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.19 per share, and an increase next year of $0.04 per share.
JPMorgan Healthcare Leaders ETF Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Celldex Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||